Amit Kumar Singh, Ph.D.

Amit Kumar Singh, Ph.D.

  • Center for Cancer Research
  • National Cancer Institute


Dr. Singh received his Ph.D. in biochemistry and molecular biology in 2017 from Central Drug Research Institute (India). He joined EIB as a postdoctoral fellow in 2017 and is currently working as a research fellow in Dr. Singer’s lab. BRD4 is a novel transcription and epigenetic regulator and a potent cancer target, Dr. Singh’s research mainly focuses on understanding the molecular mechanisms of BRD4 and its complexes.

Areas of Expertise

PhD Biochemistry And Molecular Biology